Medicare Enrolled

Dr. Rajkumar Dasgupta, M.D.

Pulmonary Disease · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
100 W CALIFORNIA BLVD, Pasadena, CA 91105
6263978300
In practice since 2006 (19 years)
NPI: 1437117421 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dasgupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dasgupta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dasgupta

Dr. Rajkumar Dasgupta is a pulmonary disease specialist in Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dasgupta performed 334 Medicare services across 247 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dasgupta received a total of $868,293 from 26 pharmaceutical and/or device companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dasgupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 334 Medicare services $868,293 industry payments

Medicare Practice Summary

Medicare Utilization ↗
334
Medicare services
Bottom 32% in CA for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
247
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
98 $65 $170
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
91 $55 $275
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
68 $100 $535
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
25 $110 $320
New patient office visit, complex (60-74 min) 16 $125 $750
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $70 $400
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $82 $400
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
12 $42 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$868,293
Total received (2018-2024)
Avg $124,042/year across 7 years
Top 1% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
787
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$816,665 (94.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,045 (5.8%)
Other
Charitable contributions, space rental, and other categories
$1,128 (0.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$455 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$178,906
2023
$205,730
2022
$107,537
2021
$87,777
2020
$49,184
2019
$143,529
2018
$95,630

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$89,074
Gilead Sciences, Inc.
$43,571
IDORSIA PHARMACEUTICALS US INC
$14,087
ANI Pharmaceuticals, Inc.
$12,620
La Jolla Pharmaceutical Company
$11,054
ModernaTX, Inc.
$4,640
Baxter Healthcare
$2,600
Philips North America LLC
$1,128
Paratek Pharmaceuticals, Inc.
$69
GENZYME CORPORATION
$36
Merck Sharp & Dohme LLC
$25
Top 3 companies account for 82.0% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$206,015
Gilead Sciences, Inc.
$148,810
IDORSIA PHARMACEUTICALS US INC
$106,418
Mallinckrodt Enterprises LLC
$91,169
Merck Sharp & Dohme Corporation
$65,121
Mallinckrodt LLC
$58,741
La Jolla Pharmaceutical Company
$54,545
Boehringer Ingelheim Pharmaceuticals, Inc.
$48,883
Merck Sharp & Dohme LLC
$25,004
ANI Pharmaceuticals, Inc.
$12,620
Jazz Pharmaceuticals Inc.
$12,430
JAZZ PHARMACEUTICALS INC.
$8,195
Advanced Respiratory, Inc
$7,611
Melinta Therapeutics, LLC
$5,847
Baxter Healthcare
$4,914
ModernaTX, Inc.
$4,640
ADVANCED RESPIRATORY, INC
$3,363
Philips Electronics North America Corporation
$2,409
Philips North America LLC
$1,128
Regeneron Healthcare Solutions, Inc.
$203
Paratek Pharmaceuticals, Inc.
$69
GENZYME CORPORATION
$61
Breathe Technologies, Inc.
$31
Fisher & Paykel Healthcare Inc
$28
Novartis Pharmaceuticals Corporation
$24
Melinta Therapeutics, Inc.
$11
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
(8269) DreamStation Cpap · (9687) Lunoa 2 0 · ACTHAR · DIFICID · DUPIXENT · FISHER & PAYKEL HEALTHCARE · GIAPREZA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Life2000 Ventilation System · Moderna Covid-19 Vaccine · NUZYRA · OFEV · PURIFIED CORTROPHIN GEL · QUVIVIQ · RECARBRIO · S&RC Und · TERLIVAZ · The MetaNeb System · The Vest System 205 Acute Care · The Vest System Model 105 Home Care · Vabomere · Veklury · XACDURO · XERAVA · XYREM · Xyrem · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pulmonary disease in CA.

Looking for a pulmonary disease specialist in Pasadena?
Compare pulmonary diseases in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
263
Per 100K population
2.7
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dasgupta is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dasgupta experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Dasgupta performed 98 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dasgupta receive payments from pharmaceutical companies?
Yes. Dr. Dasgupta received a total of $868,293 from 26 companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dasgupta's costs compare to other pulmonary diseases in Pasadena?
Dr. Dasgupta's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dasgupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →